» Articles » PMID: 39043872

Spatial Landscapes of Cancers: Insights and Opportunities

Overview
Specialty Oncology
Date 2024 Jul 23
PMID 39043872
Authors
Affiliations
Soon will be listed here.
Abstract

Solid tumours comprise many different cell types organized in spatially structured arrangements, with substantial intratumour and intertumour heterogeneity. Advances in spatial profiling technologies over the past decade hold promise to capture the complexity of these cellular architectures to build a holistic view of the intricate molecular mechanisms that shape the tumour ecosystem. Some of these mechanisms act at the cellular scale and are controlled by cell-autonomous programmes or communication between nearby cells, whereas other mechanisms result from coordinated efforts between large networks of cells and extracellular molecules organized into tissues and organs. In this Review we provide insights into the application of single-cell and spatial profiling tools, with a focus on spatially resolved transcriptomic tools developed to understand the cellular architecture of the tumour microenvironment and identify opportunities to use them to improve clinical management of cancers.

Citing Articles

Spatial transcriptomics in autoimmune rheumatic disease: potential clinical applications and perspectives.

Miyamoto A, Shimagami H, Kumanogoh A, Nishide M Inflamm Regen. 2025; 45(1):6.

PMID: 39980019 PMC: 11841260. DOI: 10.1186/s41232-025-00369-2.


Building Spatiotemporal Understanding of -Host Interactions.

Lawrence A, Tan S ACS Infect Dis. 2025; 11(2):277-286.

PMID: 39847659 PMC: 11828672. DOI: 10.1021/acsinfecdis.4c00840.


Distinct structural and functional heterochromatin partitioning of lamin B1 and lamin B2 revealed using genome-wide nicking enzyme epitope targeted DNA sequencing.

Sen S, Esteve P, Raman K, Beaulieu J, Chin H, Feehery G Nucleic Acids Res. 2025; 53(2).

PMID: 39817518 PMC: 11736435. DOI: 10.1093/nar/gkae1317.


TRAIL as a Warrior in Nano-Sized Trojan Horse: Anticancer and Anti-Metastatic Effects of Nano-Formulations of TRAIL in Cell Culture and Animal Model Studies.

Farooqi A, Turgambayeva A, Kamalbekova G, Suleimenova R, Latypova N, Ospanova S Medicina (Kaunas). 2025; 60(12.

PMID: 39768856 PMC: 11677168. DOI: 10.3390/medicina60121977.


Spatial transcriptomics in breast cancer: providing insight into tumor heterogeneity and promoting individualized therapy.

An J, Lu Y, Chen Y, Chen Y, Zhou Z, Chen J Front Immunol. 2025; 15:1499301.

PMID: 39749323 PMC: 11693744. DOI: 10.3389/fimmu.2024.1499301.


References
1.
Loi S, Drubay D, Adams S, Pruneri G, Francis P, Lacroix-Triki M . Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers. J Clin Oncol. 2019; 37(7):559-569. PMC: 7010425. DOI: 10.1200/JCO.18.01010. View

2.
Abuhadra N, Sun R, Litton J, Rauch G, Yam C, Chang J . Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer. Cancers (Basel). 2022; 14(5). PMC: 8909018. DOI: 10.3390/cancers14051323. View

3.
Berger M, Mardis E . The emerging clinical relevance of genomics in cancer medicine. Nat Rev Clin Oncol. 2018; 15(6):353-365. PMC: 6658089. DOI: 10.1038/s41571-018-0002-6. View

4.
Stuart T, Satija R . Integrative single-cell analysis. Nat Rev Genet. 2019; 20(5):257-272. DOI: 10.1038/s41576-019-0093-7. View

5.
Lim J, Chin V, Fairfax K, Moutinho C, Suan D, Ji H . Transitioning single-cell genomics into the clinic. Nat Rev Genet. 2023; 24(8):573-584. DOI: 10.1038/s41576-023-00613-w. View